91制片厂

For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Robert Sterling

Robert Sterling, PhD

Professor; Co-director, Interdisciplinary and Career-Oriented Programs; Director, Graduate Programs in Clinical Research


Department: Pharmacology & Physiology

Education

  • PhD, Applied Psychology, Hofstra University (1988)
  • MS, Applied Psychology, Hofstra University (1983)
  • BA, Psychology, Hofstra University (1981)

Awards & Honors

  • Faculty Mentoring Award, Sidney Kimmel Medical College, Thomas Jefferson University (2017)
  • Mayor鈥檚 Commission Making a Difference Award (2016)
  • Community Service Award for Applied Addiction Research, Caron Foundation (2003)

Dr. Robert C. Sterling is the co-director of the Division of Interdisciplinary and Career-Oriented Programs and the director of Graduate Programs in Clinical Research at 91制片厂. He has over thirty-five years of practical experience conducting research and publishing findings from community-based substance abuse-related research studies. He previously directed Thomas Jefferson University’s Division of Substance Abuse Programs, and he conducted applied research across a variety of clinical settings and populations. His most recent research examined psychosocial factors associated with accessing the substance use disorder treatment system and mechanisms for improving medical student training in substance use disorders. In his current role at Drexel, Dr. Sterling directs interdisciplinary master’s and certificate programs in the Graduate School of Biomedical Sciences and Professional Studies.

Research Interests

Substance use disorders, opioid use disorder, applied psychology, clinical research education

Research

Dr. Sterling鈥檚 work has redefined addiction treatment for opioid use disorder (OUD) amidst the opioid epidemic and challenged the healthcare system to improve patient outcomes and reduce relapse rates. Historically, managing OUD in hospital and outpatient settings has been inconsistent, with high readmission and low engagement rates due to limited standardized care practices. Dr. Sterling鈥檚 research focused on addressing these issues through innovative models and guidelines.

Dr. Sterling鈥檚 work implemented evidence-based withdrawal management guidelines and gauged their effects on treatment outcomes, focusing on OUD medications in hospital settings and hospital readmissions (Zavodnick et al., 2023; McFadden et al., 2022). He also evaluated pay-for-performance models in addiction care, demonstrating that financial incentives can improve adherence to agonist therapy for OUD (Loscalzo et al., 2021; Loscalzo & Sterling, 2020). Additionally, his research identified factors that discourage treatment engagement (Jaremko et al., 2015) and studied mechanisms of efficacy in drug treatment programs (Petry et al., 2005; Sterling et al., 2001; Sterling et al., 1997; Gotheil et al., 1995). His other interests include the role of spirituality in alcohol treatment and relapse (Sterling et al., 2007; Sterling et al., 2008).

Dr. Sterling鈥檚 work has influenced addiction treatment to adopt structured guidelines and incentive models, which directly benefits healthcare providers by offering more effective tools to reduce relapse and retain patients. His work has provided actionable insights into addiction management strategies with applications for care systems and direct clinical practice.

Publications

鈥淭he interaction of race and age in methadone treatment retention outcomes: A single-center analysis鈥
Alexander K, Reed MK, Sterling RC
Journal of Substance Use and Addiction Treatment. 2023 May:148:209020. doi: 10.1016/j.josat.2023.209020. PMID: 36933661

鈥淢edication initiation, patient-directed discharges, and hospital readmissions before and after implementing guidelines for opioid withdrawal management鈥
Zavodnick J, Heinsinger NM, Lepore A, Sterling RC
Journal of Addiction Medicine. 2023 Jan-Feb;17(1):e57-e63. doi: 10.1097/ADM.0000000000001053. PMID: 36001053

鈥淥UD withdrawal in a hospital setting: guideline for care and implementation disparities鈥
McFadden KM, Sterling RC, Zavodnick J
Annals of Behavioral Medicine (Vol. 56, No. SUPP 1, pp. S415-S415)

鈥淧ay for performance and treatment outcome in agonist treatment for opioid use disorder鈥
Loscalzo E, Levit A, Sterling RC, Weinstein SP
American Journal on Addictions. 2021 Mar;30(2):173-178. doi: 10.1111/ajad.13113. PMID: 33002304

鈥淎lcohol and other drug use in older adults: Results from a community needs assessment鈥
Loscalzo E, Sterling RC, Weinstein SP, Salzman B
Aging Clinical and Experimental Research. 2017 Dec;29(6):1149-1155. doi: 10.1007/s40520-016-0718-z. PMID: 28181205

Additional publications...

鈥淧sychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance鈥
Jaremko KM, Sterling RC, Van Bockstaele EJ
Journal of Substance Abuse Treatment. 2015 Jan;48(1):117-27. doi: 10.1016/j.jsat.2014.08.006. PMID: 25239858

鈥淚mpact of cannabis use during stabilization on methadone maintenance treatment鈥
Scavone J, Sterling RC, Weinstein S, Van Bockstaele E
American Journal on Addictions. 2013 Jul-Aug;22(4):344-51. doi: 10.1111/j.1521-0391.2013.12044.x. PMID: 23795873

鈥淯sing buprenorphine to treat opioid dependent university students: opportunities, successes, and challenges鈥
DeMaria P, Sterling R, Risler R, Frank J
Journal of Addiction Medicine. 2010 Dec;4(4):236-42. doi: 10.1097/ADM.0b013e3181cf2050. PMID: 21769042

鈥淢easuring recovery capital in an alcohol dependent sample鈥
Sterling R, Slusher C, Weinstein S
American Journal on Drug and Alcohol Abuse. 2008;34(5):603-10. doi: 10.1080/00952990802308114. PMID: 18821453

鈥淎 retrospective case control study of alcohol relapse and spiritual growth鈥
Sterling RC, Weinstein S, Losardo D, Raively K, Hill P, Petrone A, Gottheil E
American Journal on Addictions. 2007 Jan-Feb;16(1):56-61. doi: 10.1080/10550490601080092. PMID: 17364423

鈥淟evels of spirituality and treatment outcome: a preliminary examination鈥
Sterling RC, Weinstein S, Hill P, Gottheil E, Gordon SM, Shorie K
Journal of Studies on Alcohol. 2006 Jul;67(4):600-6. doi: 10.15288/jsa.2006.67.600. PMID: 16736080

鈥淚npatient desire to drink as a predictor of relapse to alcohol use following treatment鈥
Gordon SM, Sterling R, Siatkowski C, Raively K, Weinstein S, Hill PC
American Journal on Addictions. 2006 May-Jun;15(3):242-5. doi: 10.1080/10550490600626556. PMID: 16923671

鈥淓ffect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study鈥
Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R
Archives of General Psychiatry. 2005 Oct;62(10):1148-56. doi: 10.1001/archpsyc.62.10.1148. PMID: 16203960

鈥淕ender differences in cue exposure reactivity and 9-month outcome鈥
Sterling RC, Dean J, Weinstein SP, Murphy J, Gottheil E
Journal of Substance Abuse Treatment. 2004 Jul;27(1):39-44. doi: 10.1016/j.jsat.2004.03.008. PMID: 15223092

鈥淐orrelates of employment: A cohort study鈥
Sterling RC, Gottheil E, Glassman SD, Weinstein SP, Serota RD, Lundy A
American Journal of Drug and Alcohol Abuse. 2001 Feb;27(1):137-46. doi: 10.1081/ada-100103123. PMID: 11373031

鈥淭he effect of therapist/patient race and sex matching in individual treatment鈥
Sterling RC, Gottheil E, Weinstein SP, Serota R
Addiction. 2001 Jul;96(7):1015-22. doi: 10.1046/j.1360-0443.2001.967101511.x. PMID: 11440612

鈥淧atient treatment choice and compliance: data from a substance abuse treatment program鈥
Sterling RC, Gottheil E, Glassman SD, Weinstein SP, Serota RD
American Journal on Addictions. 1997 Spring;6(2):168-76. PMID: 9134079

鈥淕eneralizing from controlled treatment outcome studies: Sample data from a cocaine treatment program鈥
Gottheil E, Sterling RC, Weinstein SP
American Journal on Addictions. 1995. 4, 331-338


Contact Information


Graduate School of Biomedical Sciences and Professional Studies
60 N. 36th Street
Health Sciences Bldg.
Philadelphia, PA 19104